Related Experiment Videos
[Subclinical neuropathies and paraproteinemias]
Recenti Progressi in Medicina
|January 1, 1989
Summary
Monoclonal gammopathies are linked to peripheral nerve damage. Neurophysiological exams revealed subclinical neuropathy in 30% of patients with monoclonal gammopathies, even without symptoms.
Area of Science:
- Neurology
- Clinical Electrophysiology
Context:
- Monoclonal gammopathies, including monoclonal gammopathy of uncertain significance (MGUS) and multiple myeloma (MM), are associated with peripheral nerve involvement.
- Pathogenesis theories include infiltrative, compressive, ischemic, or hemorrhagic phenomena, amyloidosis, and antibody-mediated autoimmune responses against neural antigens.
Purpose:
- To investigate the prevalence of subclinical neuropathy in patients with monoclonal gammopathies using neurophysiological examinations.
- To assess the utility of nerve conduction studies and reflex testing in detecting peripheral nerve abnormalities in this patient cohort.
Summary:
- Neurophysiological examinations were performed on 35 patients with monoclonal gammopathies (MGUS, MM, MG IgM) after excluding 10 patients due to confounding factors.
- Subclinical neuropathy was detected in 11 of 35 patients (30%) who were asymptomatic.
- Carpal tunnel syndrome (CTS) was identified in 4 patients.
Impact:
- Highlights a high rate of subclinical neuropathy in asymptomatic patients with monoclonal gammopathies.
- Suggests the need for further research into the presence of subclinical neuropathy in monoclonal gammopathy of uncertain significance (MGUS) cases.